Dipo Olowookere
By Dipo Olowookere
The management of Fidson Healthcare Plc has vehemently denied planning to acquire or merge with a competitor firm, May & Baker Nigeria Plc as reported by a reputable newspaper on Monday, May 22, 2017.
In a statement issued on Thursday by Fidson, it said there was no iota of truth in the report that it May & Baker Nigeria Plc with a view to acquiring or merging with it.
It described the report as “rumour” and urged “all our stakeholders, including the Nigerian Stock Exchange (NSE) and the Securities and Exchange Commission (SEC) to disregard this unwholesome publication.
It further said the news was “baseless, speculative and unrelated and in no way connected with the decisions of the board of directors and management of Fidson Healthcare Plc.”
The leading pharmaceutical company in Nigeria said its attention was called to the publication by the NSE and it “unequivocally” stated that pursuant to the provisions of Rule 17.10, Part C, of the NSE, that it did “NOT, whether directly or indirectly nor through any Financial Consultant in any form of discussion, negotiation or consultation whatsoever, that may lead to an acquisition or a merger of the two undertakings.”
“There is no discussion of any sort either contemplated or ongoing in respect of any proposed acquisition of May & Baker Nigeria,” the firm emphasised.
